Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-03

FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for amlodipine besylate from Ascend Laboratories, LLC. Amlodipine besylate is a generic calcium channel blocker used to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine besylate (amlodipine besylate)

Snippet

SUPPL AP for AMLODIPINE BESYLATE (AMLODIPINE BESYLATE)